Literature DB >> 28215633

TLR-4/miRNA-32-5p/FSTL1 signaling regulates mycobacterial survival and inflammatory responses in Mycobacterium tuberculosis-infected macrophages.

Zhi-Min Zhang1, Ai-Rong Zhang2, Min Xu2, Jun Lou2, Wei-Qiang Qiu2.   

Abstract

Macrophages play a pivotal role in host immune response against mycobacterial infection, which is tightly modulated by multiple factors, including microRNAs. The purpose of the present study was to investigate the biological function and potential mechanism of miR-32-5p in human macrophages during Mycobacterium tuberculosis (M.tb) infection. The results demonstrated that miR-32-5p was robustly enhanced in THP-1 and U937 cells in response to M.tb infection. TLR-4 signaling was required for upregulation of miR-32-5p induced by M.tb infection. Additionally, the introduction of miR-32-5p strongly increased the survival rate of intracellular mycobacteria, whereas inhibition of miR-32-5p suppressed intracellular growth of mycobacteria during M.tb challenged. Furthermore, forced expression of miR-32-5p dramatically attenuated the accumulation of inflammatory cytokines IL-1β, IL-6 and TNF-α induced by M.tb infection. Conversely, downregulated expression of miR-32-5p led to enhancement in these inflammatory cytokines. More importantly, our study explored that Follistatin-like protein 1 (FSTL1) was a direct and functional target of miR-32-5p. qRT-PCR and western blot analysis further validated that miR-32-5p negatively regulated the expression of FSTL1. Mechanistically, re-expression of FSTL1 attenuated the ability of miR-32-5p to promote mycobacterial survival. Meanwhile, miR-32-5p-mediated inhibition of the inflammatory cytokine production were completely reversed by overexpression of FSTL1. Collectively, our findings demonstrated a novel role of TLR-4/miRNA-32-5p/FSTL1 in the modulation of host defense against mycobacterial infection, which may provide a better understanding of the pathogenesis of tuberculosis and useful information for developing potential therapeutic interventions against the disease.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammatory responses; Mycobacterial survival; Mycobacterium tuberculosis (M.tb); TLR-4/miRNA-32-5p/FSTL1 signaling

Mesh:

Substances:

Year:  2017        PMID: 28215633     DOI: 10.1016/j.yexcr.2017.02.025

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  23 in total

1.  Polymorphisms in TLR4 and TNFA and Risk of Mycobacterium tuberculosis Infection and Development of Active Disease in Contacts of Tuberculosis Cases in Brazil: A Prospective Cohort Study.

Authors:  Juan Manuel Cubillos-Angulo; María B Arriaga; Elisângela C Silva; Beatriz L A Müller; Daniela M P Ramalho; Kiyoshi F Fukutani; Pryscila F C Miranda; Adriana S R Moreira; Antonio Ruffino-Netto; Jose R Lapa E Silva; Timothy R Sterling; Afrânio L Kritski; Martha M Oliveira; Bruno B Andrade
Journal:  Clin Infect Dis       Date:  2019-08-30       Impact factor: 9.079

2.  TLR-4/microRNA-125a/NF-κB signaling modulates the immune response to Mycobacterium tuberculosis infection.

Authors:  Wenyi Niu; Bing Sun; Mingying Li; Junwei Cui; Jian Huang; Ligong Zhang
Journal:  Cell Cycle       Date:  2018-09-06       Impact factor: 4.534

Review 3.  TLRs in Mycobacterial Pathogenesis: Black and White or Shades of Gray.

Authors:  Priyanka Mehta; Atish Ray; Shibnath Mazumder
Journal:  Curr Microbiol       Date:  2021-04-12       Impact factor: 2.188

Review 4.  Follistatin-like 1 and its paralogs in heart development and cardiovascular disease.

Authors:  Martin Horak; DeLisa Fairweather; Piia Kokkonen; David Bednar; Julie Bienertova-Vasku
Journal:  Heart Fail Rev       Date:  2022-07-22       Impact factor: 4.654

5.  Circular RNA circ_HECTD1 regulates cell injury after cerebral infarction by miR-27a-3p/FSTL1 axis.

Authors:  Zhenduo Zhang; Jinbo He; Baoliang Wang
Journal:  Cell Cycle       Date:  2021-04-12       Impact factor: 4.534

6.  Inhibition of microRNA-143-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting FSTL1.

Authors:  Shunda Wang; Zhenguo Liu
Journal:  Neuromolecular Med       Date:  2021-03-11       Impact factor: 3.843

Review 7.  miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy.

Authors:  Naveed Sabir; Tariq Hussain; Syed Zahid Ali Shah; Antonio Peramo; Deming Zhao; Xiangmei Zhou
Journal:  Front Microbiol       Date:  2018-03-29       Impact factor: 5.640

Review 8.  Follistatin-like 1 in development and human diseases.

Authors:  Andrea Mattiotti; Stuti Prakash; Phil Barnett; Maurice J B van den Hoff
Journal:  Cell Mol Life Sci       Date:  2018-03-29       Impact factor: 9.261

9.  miR-200c-3p Regulates Epitelial-to-Mesenchymal Transition in Epicardial Mesothelial Cells by Targeting Epicardial Follistatin-Related Protein 1.

Authors:  Elena Pontemezzo; Eleonora Foglio; Enza Vernucci; Alessandra Magenta; Marco D'Agostino; Sara Sileno; Elena Astanina; Federico Bussolino; Laura Pellegrini; Antonia Germani; Matteo Antonio Russo; Federica Limana
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

Review 10.  Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis.

Authors:  Pavithra Sampath; Krisna Moorthi Periyasamy; Uma Devi Ranganathan; Ramalingam Bethunaickan
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.